Clinical Trials for Verismo Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Verismo Therapeutics

Clinical Trials (3)

NCT06701201
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
N/AEnrolling by invitation
60 participants
Started: Jan 27, 2025 · Completed: Feb 28, 2042
1 condition1 sponsor5 locations
NCT06544265
SynKIR-310 for Relapsed/Refractory B-NHL
PHASE1Recruiting
18 participants
Started: Nov 1, 2024 · Completed: Dec 31, 2028
24 conditions1 sponsor5 locations
NCT05568680
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
PHASE1Recruiting
42 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor4 locations